# US 2021/0095265 A1 · In vitro methods for processing lignin and other aromatic compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0095265 A1
- Document ID: US20210095265A1
- Status: Published application
- Kind: A1
- Application number: 17/038,971
- Filed: 2020-09-30
- Published: 2021-04-01
- Earliest claimed: 2017-08-14
- Assignees: Wisconsin Alumni Research Foundation
- Applicants: Wisconsin Alumni Research Foundation
- Inventors: Timothy James Donohue; Daniel Leo Gall; Wayne S. Kontur; Hoon Kim; John Ralph; Daniel R. Noguera; Brian Fox; Craig Bingman
- Web page: https://patentgrep.com/patent/US20210095265A1

## CPC

- C12N 9/1088: {Glutathione transferase (2.5.1.18)}
- C12P 7/22: aromatic
- C12P 7/26: Ketones
- C12N 9/88: Lyases (4.)
- C12Y 114/16005: Alkylglycerol monooxygenase (1.14.16.5)
- C12Y 205/01018: Glutathione transferase (2.5.1.18)
- Y02P 20/582: Recycling of unreacted starting or intermediate materials
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

Enzymes for depolymerizing lignin. The enzymes include dehydrogenases, β-etherases, and glutathione lyases. The dehydrogenases can comprise one or more or LigD, LigO, LigN, and LigL. The β-etherases can comprise one or more of LigE, LigF, LigP, and BaeA. The glutathione lyases can comprise any one or more of LigG and a number of non-stereospecific, optionally recombinant glutathione lyases derived from Sphingobium sp. SYK-6, Novosphingobium aromaticivorans, Escherichia coli, Streptococcus sanguinis, Phanerochaete chrysosporium, and other microorganisms. The enzymes can be combined in compositions and/or used in methods of processing lignin or other aromatic compounds in vitro.

## Claims

### Claim at position 1

1-20. (canceled)

### Claim 21

A method of chemical conversion, comprising contacting a first compound in vitro with a non-stereospecific glutathione lyase to yield a second compound, wherein:
the non-stereospecific glutathione lyase comprises:
an amino acid sequence at least 80% identical to any of:
SEQ ID NO: 18 (NaGSTNu);
residues 21-313 of SEQ ID NO: 20 (recombinant
NaGSTNu);
SEQ ID NO: 22 (SYK6GSTNu);
residues 21-324 of SEQ ID NO: 24 (recombinant
SYK6GSTNu);
SEQ ID NO: 26 (ecYghU);
residues 21-313 of SEQ ID NO: 28 (recombinant
ecYghU);
SEQ ID NO: 30 (ecYfcG);
SEQ ID NO: 32 (ssYghU);
and
SEQ ID NO: 36 (PcUre2pB 1);
and
at least four of:
threonine or a conservative variant of threonine at a position corresponding to position 51 of SEQ ID NO:18 (NaGSTNu);
asparagine or a conservative variant of asparagine at a position corresponding to position 53 of SEQ ID NO:18 (NaGSTNu);
glutamine or a conservative variant of glutamine at a position corresponding to position 86 of SEQ ID NO:18 (NaGSTNu);
lysine, a conservative variant of lysine, arginine, or a conservative variant of arginine at a position corresponding to position 99 of SEQ ID NO:18 (NaGSTNu);
isoleucine or a conservative variant of isoleucine at a position corresponding to position 100 of SEQ ID NO:18 (NaGSTNu);
glutamate or a conservative variant of glutamate at a position corresponding to position 116 of SEQ ID NO:18 (NaGSTNu);
serine, threonine, a conservative variant of serine, or a conservative variant of threonine at a position corresponding to position 117 of SEQ ID NO:18 (NaGSTNu); and
arginine or a conservative variant of arginine at a position corresponding
to position 177 of SEQ ID NO:18 (NaGSTNu);
the first compound has a structure of Formula I or a salt thereof:
wherein:
R1, R2, and R3 are each independently —H, —OH, —O-alkyl, —O-lignin, or -lignin;
R4 is —H, —OH, —SH, —COOH, —SO3H, or —O-lignin; and
SG is glutathione bound in an S or R configuration; and
the second compound has a structure of Formula II or a salt thereof:
wherein:
R1, R2, and R3 are each independently —H, —OH, —O-alkyl, —O-lignin, or -lignin; and
R4 is —H, —OH, —SH, —COOH, —SO3H, or —O-lignin.

### Claim 22 (depends on 21)

The method of claim 21, wherein the non-stereospecific glutathione lyase comprises an amino acid sequence at least about 85% identical to any of:
SEQ ID NO: 18 (NaGSTNu);
residues 21-313 of SEQ ID NO: 20 (recombinant
NaGSTNu);
SEQ ID NO: 22 (SYK6GSTNu);
residues 21-324 of SEQ ID NO: 24 (recombinant
SYK6GSTNu);
SEQ ID NO: 26 (ecYghU);
residues 21-313 of SEQ ID NO: 28 (recombinant
ecYghU);
SEQ ID NO: 30 (ecYfcG);
SEQ ID NO: 32 (ssYghU);
and
SEQ ID NO: 36 (PcUre2pB1).

### Claim 23 (depends on 21)

The method of claim 21, wherein the non-stereospecific glutathione lyase comprises an amino acid sequence at least about 90% identical to any of:
SEQ ID NO: 18 (NaGSTNu);
residues 21-313 of SEQ ID NO: 20 (recombinant
NaGSTNu);
SEQ ID NO: 22 (SYK6GSTNu);
residues 21-324 of SEQ ID NO: 24 (recombinant
SYK6GSTNu);
SEQ ID NO: 26 (ecYghU);
residues 21-313 of SEQ ID NO: 28 (recombinant
ecYghU);
SEQ ID NO: 30 (ecYfcG);
SEQ ID NO: 32 (ssYghU);
and
SEQ ID NO: 36 (PcUre2pB1).

### Claim 24 (depends on 1)

The method of claim 1, wherein the non-stereospecific glutathione lyase comprises an amino acid sequence at least about 95% identical to any of:
SEQ ID NO: 18 (NaGSTNu);
residues 21-313 of SEQ ID NO: 20 (recombinant
NaGSTNu);
SEQ ID NO: 22 (SYK6GSTNu);
residues 21-324 of SEQ ID NO: 24 (recombinant
SYK6GSTNu);
SEQ ID NO: 26 (ecYghU);
residues 21-313 of SEQ ID NO: 28 (recombinant
ecYghU);
SEQ ID NO: 30 (ecYfcG);
SEQ ID NO: 32 (ssYghU);
and
SEQ ID NO: 36 (PcUre2pB1).

### Claim 25 (depends on 21)

The method of claim 21, wherein the non-stereospecific glutathione lyase comprises at least seven of:
asparagine or a conservative variant of asparagine at a position corresponding to position 25 of SEQ ID NO:18 (NaGSTNu);
threonine or a conservative variant of threonine at a position corresponding to position 51 of SEQ ID NO:18 (NaGSTNu);
asparagine or a conservative variant of asparagine at a position corresponding to position 53 of SEQ ID NO:18 (NaGSTNu);
glutamine or a conservative variant of glutamine at a position corresponding to position 86 of SEQ ID NO:18 (NaGSTNu);
lysine, a conservative variant of lysine, arginine, or a conservative variant of arginine at a position corresponding to position 99 of SEQ ID NO:18 (NaGSTNu);
isoleucine or a conservative variant of isoleucine at a position corresponding to position 100 of SEQ ID NO:18 (NaGSTNu);
glutamate or a conservative variant of glutamate at a position corresponding to position 116 of SEQ ID NO:18 (NaGSTNu);
serine, threonine, a conservative variant of serine, or a conservative variant of threonine at a position corresponding to position 117 of SEQ ID NO:18 (NaGSTNu);
tyrosine or a conservative variant of tyrosine at a position corresponding to position 166 of SEQ ID NO:18 (NaGSTNu);
arginine or a conservative variant of arginine at a position corresponding to position 177 of SEQ ID NO:18 (NaGSTNu); and
tyrosine or a conservative variant of tyrosine at a position corresponding to position 224 of SEQ ID NO:18 (NaGSTNu).

### Claim 26 (depends on 21)

The method of claim 21, wherein the contacting occurs in the presence of a glutathione (GSH) reductase that catalyzes reduction of glutathione disulfide (GSSG).

### Claim 27 (depends on 21)

The method of claim 21, wherein the GSH reductase comprises an amino acid sequence at least about 95% identical to SEQ ID NO:38 (AvGR).

### Claim 28 (depends on 21)

The method of claim 21, wherein the non-stereospecific glutathione lyase comprises an amino acid sequence at least 80% identical to any of:
SEQ ID NO: 18 (NaGSTNu);
residues 21-313 of SEQ ID NO: 20 (recombinant
NaGSTNu);
SEQ ID NO: 22 (SYK6GSTNu);
residues 21-324 of SEQ ID NO: 24 (recombinant
SYK6GSTNu);
SEQ ID NO: 26 (ecYghU);
residues 21-313 of SEQ ID NO: 28 (recombinant
ecYghU);
and
SEQ ID NO: 32 (ssYghU).

### Claim 29 (depends on 28)

The method of claim 28, wherein the non-stereospecific glutathione lyase comprises an amino acid sequence at least about 85% identical to any of:
SEQ ID NO: 18 (NaGSTNu);
residues 21-313 of SEQ ID NO: 20 (recombinant
NaGSTNu);
SEQ ID NO: 22 (SYK6GSTNu);
residues 21-324 of SEQ ID NO: 24 (recombinant
SYK6GSTNu);
SEQ ID NO: 26 (ecYghU);
residues 21-313 of SEQ ID NO: 28 (recombinant
ecYghU);
and
SEQ ID NO: 32 (ssYghU).

### Claim 30 (depends on 28)

The method of claim 28, wherein the non-stereospecific glutathione lyase comprises an amino acid sequence at least about 90% identical to any of:
SEQ ID NO: 18 (NaGSTNu);
residues 21-313 of SEQ ID NO: 20 (recombinant
NaGSTNu);
SEQ ID NO: 22 (SYK6GSTNu);
residues 21-324 of SEQ ID NO: 24 (recombinant
SYK6GSTNu);
SEQ ID NO: 26 (ecYghU);
residues 21-313 of SEQ ID NO: 28 (recombinant
ecYghU);
and
SEQ ID NO: 32 (ssYghU).

### Claim 31 (depends on 28)

The method of claim 28, wherein the non-stereospecific glutathione lyase comprises an amino acid sequence at least about 95% identical to any of:
SEQ ID NO: 18 (NaGSTNu);
residues 21-313 of SEQ ID NO: 20 (recombinant
NaGSTNu);
SEQ ID NO: 22 (SYK6GSTNu);
residues 21-324 of SEQ ID NO: 24 (recombinant
SYK6GSTNu);
SEQ ID NO: 26 (ecYghU);
residues 21-313 of SEQ ID NO: 28 (recombinant
ecYghU);
and
SEQ ID NO: 32 (ssYghU).

### Claim 32 (depends on 28)

The method of claim 28, wherein the non-stereospecific glutathione lyase comprises at least seven of:
asparagine or a conservative variant of asparagine at a position corresponding to position 25 of SEQ ID NO:18 (NaGSTNu);
threonine or a conservative variant of threonine at a position corresponding to position 51 of SEQ ID NO:18 (NaGSTNu);
asparagine or a conservative variant of asparagine at a position corresponding to position 53 of SEQ ID NO:18 (NaGSTNu);
glutamine or a conservative variant of glutamine at a position corresponding to position 86 of SEQ ID NO:18 (NaGSTNu);
lysine, a conservative variant of lysine, arginine, or a conservative variant of arginine at a position corresponding to position 99 of SEQ ID NO:18 (NaGSTNu);
isoleucine or a conservative variant of isoleucine at a position corresponding to position 100 of SEQ ID NO:18 (NaGSTNu);
glutamate or a conservative variant of glutamate at a position corresponding to position 116 of SEQ ID NO:18 (NaGSTNu);
serine, threonine, a conservative variant of serine, or a conservative variant of threonine at a position corresponding to position 117 of SEQ ID NO:18 (NaGSTNu);
tyrosine or a conservative variant of tyrosine at a position corresponding to position 166 of SEQ ID NO:18 (NaGSTNu);
arginine or a conservative variant of arginine at a position corresponding to position 177 of SEQ ID NO:18 (NaGSTNu); and
tyrosine or a conservative variant of tyrosine at a position corresponding to position 224 of SEQ ID NO:18 (NaGSTNu).

### Claim 33 (depends on 28)

The method of claim 28, wherein the contacting occurs in the presence of a glutathione (GSH) reductase that catalyzes reduction of glutathione disulfide (GSSG).

### Claim 34 (depends on 28)

The method of claim 28, wherein the GSH reductase comprises an amino acid sequence at least about 95% identical to SEQ ID NO:38 (AvGR).

### Claim 35 (depends on 21)

The method of claim 21, wherein the non-stereospecific glutathione lyase comprises an amino acid sequence at least 80% identical to any of:
SEQ ID NO: 18 (NaGSTNu);
residues 21-313 of SEQ ID NO: 20 (recombinant
NaGSTNu);
SEQ ID NO: 22 (SYK6GSTNu);
residues 21-324 of SEQ ID NO: 24 (recombinant
SYK6GSTNu);
SEQ ID NO: 26 (ecYghU);
and
residues 21-313 of SEQ ID NO: 28 (recombinant
ecYghU).

### Claim 36 (depends on 35)

The method of claim 35, wherein the non-stereospecific glutathione lyase comprises an amino acid sequence at least about 85% identical to any of:
SEQ ID NO: 18 (NaGSTNu);
residues 21-313 of SEQ ID NO: 20 (recombinant
NaGSTNu);
SEQ ID NO: 22 (SYK6GSTNu);
residues 21-324 of SEQ ID NO: 24 (recombinant
SYK6GSTNu);
SEQ ID NO: 26 (ecYghU);
and
residues 21-313 of SEQ ID NO: 28 (recombinant
ecYghU).

### Claim 37 (depends on 35)

The method of claim 35, wherein the non-stereospecific glutathione lyase comprises an amino acid sequence at least about 90% identical to any of:
SEQ ID NO: 18 (NaGSTNu);
residues 21-313 of SEQ ID NO: 20 (recombinant
NaGSTNu);
SEQ ID NO: 22 (SYK6GSTNu);
residues 21-324 of SEQ ID NO: 24 (recombinant
SYK6GSTNu);
SEQ ID NO: 26 (ecYghU);
and
residues 21-313 of SEQ ID NO: 28 (recombinant
ecYghU).

### Claim 38 (depends on 35)

The method of claim 35, wherein the non-stereospecific glutathione lyase comprises an amino acid sequence at least about 95% identical to any of:
SEQ ID NO: 18 (NaGSTNu);
residues 21-313 of SEQ ID NO: 20 (recombinant
NaGSTNu);
SEQ ID NO: 22 (SYK6GSTNu);
residues 21-324 of SEQ ID NO: 24 (recombinant
SYK6GSTNu);
SEQ ID NO: 26 (ecYghU);
and
residues 21-313 of SEQ ID NO: 28 (recombinant
ecYghU).

### Claim 39 (depends on 35)

The method of claim 35, wherein the non-stereospecific glutathione lyase comprises at least seven of:
asparagine or a conservative variant of asparagine at a position corresponding to position 25 of
SEQ ID NO:18 (NaGSTNu);
threonine or a conservative variant of threonine at a position corresponding to position 51 of SEQ ID NO:18 (NaGSTNu);
asparagine or a conservative variant of asparagine at a position corresponding to position 53 of SEQ ID NO:18 (NaGSTNu);
glutamine or a conservative variant of glutamine at a position corresponding to position 86 of SEQ ID NO:18 (NaGSTNu);
lysine, a conservative variant of lysine, arginine, or a conservative variant of arginine at a position corresponding to position 99 of SEQ ID NO:18 (NaGSTNu);
isoleucine or a conservative variant of isoleucine at a position corresponding to position 100 of SEQ ID NO:18 (NaGSTNu);
glutamate or a conservative variant of glutamate at a position corresponding to position 116 of SEQ ID NO:18 (NaGSTNu);
serine, threonine, a conservative variant of serine, or a conservative variant of threonine at a position corresponding to position 117 of SEQ ID NO:18 (NaGSTNu);
tyrosine or a conservative variant of tyrosine at a position corresponding to position 166 of SEQ ID NO:18 (NaGSTNu);
arginine or a conservative variant of arginine at a position corresponding to position 177 of SEQ ID NO:18 (NaGSTNu); and
tyrosine or a conservative variant of tyrosine at a position corresponding to position 224 of SEQ ID NO:18 (NaGSTNu).

### Claim 40 (depends on 35)

The method of claim 35, wherein the contacting occurs in the presence of a glutathione (GSH) reductase that catalyzes reduction of glutathione disulfide (GSSG).

### Claim 41 (depends on 35)

The method of claim 35, wherein the GSH reductase comprises an amino acid sequence at least about 95% identical to SEQ ID NO:38 (AvGR).
